Nobuto Arashiki

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Vascular Endothelial Growth Factor

Inflammatory Response

Ankylosing Spondylitis

Top Venues

Cancer gene therapy

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Atsuko Deguchi, Miho Watanabe-Takahashi, Taishi Mishima, Tsutomu Omori, Umeharu Ohto, Nobuto Arashiki, Fumio Nakamura, Kiyotaka Nishikawa, Yoshiro Maru
Novel multivalent S100A8 inhibitory peptides attenuate tumor progression and metastasis by inhibiting the TLR4-dependent pathway. Cancer gene therapy (2023)
Atsuko Deguchi, Miho Watanabe-Takahashi, Taishi Mishima, Tsutomu Omori, Umeharu Ohto, Nobuto Arashiki, Fumio Nakamura, Kiyotaka Nishikawa, Yoshiro Maru
Novel multivalent S100A8 inhibitory peptides attenuate tumor progression and metastasis by inhibiting the TLR4-dependent pathway. Cancer gene therapy (2023)
Momoko Seki, Nobuto Arashiki, Yuichi Takakuwa, Kosaku Nitta, Fumio Nakamura
Reduction in flippase activity contributes to surface presentation of phosphatidylserine in human senescent erythrocytes. Journal of cellular and molecular medicine 24 (23) (2020)